Simple, Rapid and Sensitive Electrochemical Method for the Determination of the Triketone Herbicide Sulcotrione in River Water Using a Glassy Carbon Electrode

We report a novel, simple, rapid and sensitive electrochemical method for the determination of sulcotrione, a member of the relatively new class of triketone herbicides, using differential pulse voltammetry on a glassy carbon electrode. Its electrochemical behavior including influences of electrolyte composition, pH and scan rate was studied to select optimal experimental parameters for its determination. In Britton-Robinson buffer at pH 3 sulcotrione provided a well-defined reduction peak at -0.84 V (vs. Ag/AgCl electrode), with good repeatability (relative standard deviation of 2.3% for 8 measurements at 10 mu M concentration level). With optimized parameters differential pulse voltammetry rendered two linear concentration ranges from 0.2 to 2 mu M and from 2 to 50 mM with a detection limit of 0.05 mu M. The proposed procedure was successfully applied to the determination of sulcotrione in spiked river water samples with satisfactory recoveries (93-109%). The developed method may represent a simple, rapid and sensitive alternative to highly toxic mercury electrodes and chromatographic methods.Supplementary material: [http://cherry.chem.bg.ac.rs/handle/123456789/3419

Impact of HLA-G 14 bp polymorphism and soluble HLA-G level on kidney graft outcome

Human leukocyte antigen G (HLA-G) is a non-classical HLA class I protein with various immunosuppressive functions. Besides its profound effect to induce fetal tolerance, HLA-G has been also found to enhance graft acceptance. The aim of the study was to analyse the association between HLA-G 14 bp insertion/deletion polymorphism, soluble HLA-G level and kidney graft outcome in the Slovak population. We investigated 69 kidney transplant recipients aged 27–65 years. Out of this group, 37 recipients developed acute rejection, confirmed by biopsy, and 32 patients had stable allograft function. Plasma was obtained from recipients at 1 day before transplantation and analyzed by ELISA. Genotyping of HLA-G polymorphism was performed by PCR. Significantly higher pre-transplantation levels of sHLA-G were found in the group with stable allograft function in comparison to group with acute rejection (P = 0.0409). In the homozygous −14/−14 recipients with stable allograft function, significantly higher values of sHLA-G were determined in comparison to the recipients with acute rejection (P = 0.0052). The study revealed an association between 14 bp deletion polymorphism and soluble HLA-G level that is proportional to kidney graft acceptance. It is suggested that pre-transplantation levels of soluble HLA-G should be monitored as additional marker to predict kidney graft outcome

Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients

HLA-G is the checkpoint molecule involved in the suppression of the immune response. Increased expression of HLA-G and its ILTs receptors have been correlated with tumor progression in various cancer types. In head and neck squamous cell carcinoma (HNSCC) tumors, the effect of HLA-G, ILT2 and ILT4 expression on cancer development has to be explained. The 34 HNSCC patients and 98 controls were genotyped for the HLA-G 14 bp ins/del polymorphism. In HNSCC lesions, HLA-G, ILT2 and ILT4 mRNA expression was analysed using real-time PCR. The association between HLA-G, ILT2 and ILT4 mRNA expression and clinical variables (age at onset, TNM staging system and p16 positivity) was also evaluated. No genetic association between the HLA-G 14 bp ins/del and HNSCC risk was detected (p > 0.05). However, in the non-metastatic HNSCC group, a significantly higher HLA-G mRNA expression was noted in tumors in the T4 stage compared to those in the T1 and T2 stages (p = 0.0289). ILT2 mRNA expression was significantly increased in non-metastatic vs. metastatic tumors (p = 0.0269). Furthermore, a significantly higher ILT4 mRNA expression was noted in tumors in the T1+T2 stage compared to those in the T3 stage (p = 0.0495). Our results suggest that the HLA-G molecule creates an immunological microenvironment involved in HNSCC development